BRIEF-Omeros to present results from dose-ranging stage of OMS721 Clinical Trial
March 27, 2017 at 07:23 AM EDT
* Omeros to present results from dose-ranging stage of oms721 clinical trial in atypical hemolytic uremic syndrome at world congress of nephrology
